ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,040Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 252

$802K Total Retail Price of All Prescriptions

Rank: 33 out of 252

499 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 14,326 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
OMEPRAZOLE 739 601 1 6
SIMVASTATIN 714 619 2 2
AMLODIPINE BESYLATE 667 557 3 4
LEVOTHYROXINE SODIUM 520 459 4 1
FUROSEMIDE 489 426 5 7
CITALOPRAM HBR 469 420 6 15
LISINOPRIL 463 377 7 3
HYDROCODONE-ACETAMINOPHEN 443 281 S3 8 5
GABAPENTIN 430 350 9 11
POTASSIUM CHLORIDE 399 327 10 8
WARFARIN SODIUM 333 328 11 14
TRAMADOL HCL 327 250 12 17
PRAVASTATIN SODIUM 325 229 13 12
SERTRALINE HCL 315 252 14 27
CHLORTHALIDONE 299 275 15 141
GLIMEPIRIDE 248 207 16 40
LANTUS 244 183 17 55
METOPROLOL TARTRATE 236 203 18 10
METFORMIN HCL 231 112 19 9
ATENOLOL 229 196 20 18
NEXIUM 220 121 21 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 114 22 25
CLOPIDOGREL 201 188 22 29
ATORVASTATIN CALCIUM 197 147 24 16
ZOLPIDEM TARTRATE 196 151 25 21
FLUTICASONE PROPIONATE 188 118 26 36
TAMSULOSIN HCL 179 158 27 26
CARVEDILOL 177 147 28 22
DONEPEZIL HCL 162 158 29 28
LOSARTAN POTASSIUM 155 129 30 24
RISPERIDONE 154 141 31 81
OXYCODONE-ACETAMINOPHEN 153 118 S2 32 144
CEFUROXIME 151 130 33 114
LEVOFLOXACIN 139 97 34 79
AMLODIPINE BESYLATE-BENAZEPRIL 123 118 35 60
PLAVIX 119 113 36 43
KLOR-CON M20 115 103 37 69
POLYETHYLENE GLYCOL 3350 114 98 38 67
DIOVAN 113 100 39 38
HYDROCHLOROTHIAZIDE 110 89 40 13
ADVAIR DISKUS 110 70 40 63
ESCITALOPRAM OXALATE 109 90 42 56
ROPINIROLE HCL 102 80 43 84
FAMOTIDINE 95 82 44 59
RAMIPRIL 94 94 45 71
LYRICA 93 48 46 66
METHADONE HCL 93 43 S2 46 161
ISOSORBIDE MONONITRATE ER 92 92 48 50
CRESTOR 88 64 49 34
LIPITOR 88 73 49 112
PROAIR HFA 88 53 49 54
CLONIDINE HCL 88 79 49 35
ALLOPURINOL 84 68 53 30
NAMENDA 83 83 54 41
FENTANYL 82 68 S2 55 126
NYSTATIN 82 61 55 171
TRAZODONE HCL 81 57 57 31
DIGOXIN 78 73 58 44
LOSARTAN-HYDROCHLOROTHIAZIDE 73 56 59 49
CYCLOBENZAPRINE HCL 68 36 R 60 51
MORPHINE SULFATE ER 66 29 S2 61 127
PAROXETINE HCL 66 61 61 75
TAMIFLU 64 59 63 249
MORPHINE SULFATE 62 38 S2 64 330
DOXYCYCLINE HYCLATE 61 52 65 92
DIOVAN HCT 61 47 65 65
AMIODARONE HCL 58 58 67 142
SPIRONOLACTONE 58 34 67 53
GLYBURIDE-METFORMIN HCL 57 51 R 69 82
INSULIN SYRINGE 57 25 69 93
ISOSORBIDE MONONITRATE 57 57 69 342
FINASTERIDE 56 41 72 115
DILTIAZEM ER 55 48 73 86
OXYCODONE HCL-ACETAMINOPHEN 54 43 S2 74 175
FLUOXETINE HCL 54 36 74 57
QUINAPRIL HCL 53 45 76 120
BENAZEPRIL HCL 52 50 77 80
SPIRIVA 52 40 77 68
COMBIVENT 51 26 79 123
VERAPAMIL ER 50 39 80 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.